News

Bank of Montreal BMO recently initiated a process to sell some of its U.S. branches, which hold approximately $6 billion in deposits, per the Wall Street Journal, as cited by Reuters, citing people

It was a week when oil prices remained nearly the same, while natural gas fell.

Headlines centered on the merger of energy explorers California Resources Corporation (CRC) and Berry Corporation (BRY

Root Inc.’s ROOT profitability is underpinned by its combined ratio, a key measure of underwriting performance. A combined ratio — defined as sum of loss ratio and expense ratio — below 100% signals

Intuit Inc. INTU has made significant strides with its proprietary Generative AI Operating System (GenOS), advancing its capabilities rapidly over just the past 90 days. The company aims to

The Zacks Medical - Outpatient and Home Healthcare industry has been witnessing a rapid shift toward digital healthcare treatment. In the past few years, there has been a significant rise in demand

Rigetti Computing RGTI has secured a series of significant grants over the past six months, underscoring both government confidence and the commercial relevance of its quantum roadmap. Most

Select Medical Holdings Corporation SEM has had a brutal run so far in 2025. Shares have plunged 33.4% year to date, sharply lagging the industry’s 29.7% gain and the S&P 500’s 14.2% growth

Archer Daniels Midland Company ADM is focused on optimizing the organizational and operational structure across Human and Animal Nutrition. In the latest development, the company, in collaboration

Morgan Stanley MS has collaborated with Zerohash, a cryptocurrency infrastructure provider, enabling E*TRADE clients to trade in popular cryptocurrencies starting in the first half of 2026. This was

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth

Biogen BIIB announced that the FDA has issued a complete response letter (CRL) to its supplemental new drug application (sNDA) seeking label expansion for a higher dose of its renowned spinal

Symbotic SYM and Duolingo DUOL are well-established names in the Zacks Technology Services industry. Symbotic, based in Wilmington, MA, develops, commercializes, and deploys innovative

TradePMR, a subsidiary of Robinhood Markets, Inc. HOOD, has introduced the “Asset Match” feature for independent registered investment advisers (RIAs). This will enable independent RIAs to offer

Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their GLP-1 products.  Lilly markets its dual GIP and GLP-1 receptor agonist

Alamos Gold Inc. AGI scaled a new 52-week high of $34.40 yesterday before ending the session at $33.79. The upside follows record metal prices and the news of the company agreeing to sell its

Investors might want to bet on HF Sinclair (DINO), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of

Lynas Corp. (LYSDY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the

Investors might want to bet on Marubeni Corp. (MARUY), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

Hengan International Group Co., Ltd. Unsponsored ADR (HEGIY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in

Medicenna Therapeutics Corp. (MDNAF) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in

Blachem (BCPC) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock